We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Immobilized Lytic Enzymes Prevent Listeria Growth on Food-related Surfaces

By LabMedica International staff writers
Posted on 18 Apr 2013
Print article
A coating of stabilized bacteriophage lytic enzymes could prevent Listeria from surviving on equipment and packaging used in the food industry.

Listeria is a genus of bacteria, of which the most common species is Listeria monocytogenes, commonly found in soil, on unwashed vegetables, and in unpasteurized soft cheeses. These bacteria resist cold and the presence of salt and can cause food poisoning (listeriosis) with flu-like symptoms such as high fever and dizziness. While healthy individuals may not have any symptoms, those with compromised immune systems such as pregnant women, infants, and the elderly are especially at risk.

Investigators at Rensselaer Polytechnic Institute (Troy, NY, USA) previously developed a coating that could kill methicillin-resistant Staphylococcus aureus (MRSA) without antibiotics. In the present study, they observed that while a number of phage cell lytic enzymes against Listeria had been isolated, no attempt had been made to incorporate these enzymes onto surfaces.

The investigators described in the April 2, 2013, online edition of the journal Scientific Reports the development of three simple routes for the surface incorporation of the Listeria bacteriophage endolysin Ply500. These routes included covalent attachment onto [US] Food and Drugs Administration (FDA)-approved silica nanoparticles (SNPs), incorporation of SNP-Ply500 conjugates into a thin poly(hydroxyethyl methacrylate) film, and affinity binding to edible crosslinked starch nanoparticles via construction of a maltose binding protein fusion.

Testing of these coated surfaces revealed that these Ply500 formulations were effective in killing L. innocua (a reduced pathogenic surrogate) at challenges up to 100,000 colony-forming units per milliliter both in non-growth-sustaining buffer solution as well as under growth conditions on lettuce. This is a significantly higher concentration of bacteria than is normally found in contaminated food.

"In this study, we have identified a new strategy for selectively killing specific types of bacteria. Stable enzyme-based coatings or sprays could be used in food supply infrastructure—from picking equipment to packaging to preparation—to kill Listeria before anyone has a chance to get sick from it," said contributing author Dr. Ravi Kane, professor of chemical and biological engineering at Rensselaer Polytechnic Institute. "What is most exciting is that we can adapt this technology for all different kinds of harmful or deadly bacteria."

Related Links:
Rensselaer Polytechnic Institute


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The utilization of liquid biopsies in cancer research is a rapidly developing field (Photo courtesy of Lightspring/Shutterstock)

Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis

B-cell lymphoma is the predominant form of cancer affecting the lymphatic system, with about 30% of patients with aggressive forms of this disease experiencing relapse. Currently, the disease’s risk assessment... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Sampler device could revolutionize sample collection for diagnostic tests (Photo courtesy of ReadyGo Diagnostics)

First of Its Kind Universal Tool to Revolutionize Sample Collection for Diagnostic Tests

The COVID pandemic has dramatically reshaped the perception of diagnostics. Post the pandemic, a groundbreaking device that combines sample collection and processing into a single, easy-to-use disposable... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.